Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2011, Article ID 397618, 7 pages
http://dx.doi.org/10.1155/2011/397618
Research Article

Procalcitonin: A Key Marker in Children with Urinary Tract Infection

1Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Linton Road, Oxford OX2 6UD, UK
2Pasteur Institute, 75015 Paris, France
3Department of Pediatrics, University Hospital of Geneva, 1211 Geneva, Switzerland

Received 1 November 2010; Revised 20 December 2010; Accepted 21 December 2010

Academic Editor: Ming Hsien Wang

Copyright © 2011 Sandrine Leroy and Alain Gervaix. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Shaikh, N. E. Morone, J. E. Bost, and M. H. Farrell, “Prevalence of urinary tract infection in childhood: a meta-analysis,” Pediatric Infectious Disease Journal, vol. 27, no. 4, pp. 302–308, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. Mårild and U. Jodal, “Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age,” Acta Paediatrica, vol. 87, no. 5, pp. 549–552, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Vernon, M. G. Coulthard, H. J. Lambert, M. J. Keir, and J. N. S. Matthews, “New renal scarring in children who at age 3 and 4 years had had normal scans with dimercaptosuccinic acid: follow up study,” British Medical Journal, vol. 315, no. 7113, pp. 905–908, 1997. View at Google Scholar · View at Scopus
  4. S. M. Downs, “Technical report: urinary tract infections in febrile infants and young children. The Urinary Tract Subcommittee of the American Academy of Pediatrics Committee on Quality Improvement,” Pediatrics, vol. 103, no. 4, p. e54, 1999. View at Google Scholar · View at Scopus
  5. Committee on Quality Improvement, Subcommittee on Urinary Tract Infection, “Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children,” Pediatrics, vol. 103, no. 4, pp. 843–852, 1999. View at Google Scholar
  6. M. G. Coulthard, “NICE on childhood UTI: nasty processes produce nasty guidelines,” BMJ, vol. 335, no. 7618, pp. 463–464, 2007. View at Google Scholar · View at Scopus
  7. M. G. Coulthard, “Is reflux nephropathy preventable, and will the NICE childhood UTI guidelines help?” Archives of Disease in Childhood, vol. 93, no. 3, pp. 196–199, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. R. Mori, M. Lakhanpaul, and K. Verrier-Jones, “Diagnosis and management of urinary tract infection in children: summary of NICE guidance,” British Medical Journal, vol. 335, no. 7616, pp. 395–397, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Assicot, D. Gendrel, H. Carsin, J. Raymond, J. Guilbaud, and C. Bohuon, “High serum procalcitonin concentrations in patients with sepsis and infection,” Lancet, vol. 341, no. 8844, pp. 515–518, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Simon, F. Gauvin, D. K. Amre, P. Saint-Louis, and J. Lacroix, “Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis,” Clinical Infectious Diseases, vol. 39, no. 2, pp. 206–217, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. Whicher, J. Bienvenu, and G. Monneret, “Procalcitonin as an acute phase marker,” Annals of Clinical Biochemistry, vol. 38, no. 5, pp. 483–493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Müller, J. C. White, E. S. Nylén, R. H. Snider, K. L. Becker, and J. F. Habener, “Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 396–404, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Meisner, “Biomarkers of sepsis: clinically useful?” Current Opinion in Critical Care, vol. 11, no. 5, pp. 473–480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. Lavocat, D. Granjon, D. Allard, C. Gay, M. T. Freycon, and F. Dubois, “Imaging of pyelonephritis,” Pediatric Radiology, vol. 27, no. 2, pp. 159–165, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kotoula, S. Gardikis, and S. Gardikis, “Procalcitonin for the early prediction of renal parenchymal involvement in children with UTI: preliminary results,” International Urology and Nephrology, vol. 41, no. 2, pp. 393–399, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. Pecile, E. Miorin, C. Romanello, E. Falleti, F. Valent, F. Giacomuzzi, and A. Tenore, “Procalcitonin: a marker of severity of acute pyelonephritis among children,” Pediatrics, vol. 114, no. 2, pp. e249–e254, 2004. View at Google Scholar · View at Scopus
  17. S. Bressan, B. Andreola, P. Zucchetta, G. Montini, M. Burei, G. Perilongo, and L. Da Dalt, “Procalcitonin as a predictor of renal scarring in infants and young children,” Pediatric Nephrology, vol. 24, no. 6, pp. 1199–1204, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. M. K. Gürgöze, S. Akarsu, E. Yilmaz, A. Gödekmerdan, Z. Akça, I. Çiftçi, and A. D. Aygün, “Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis,” Pediatric Nephrology, vol. 20, no. 10, pp. 1445–1448, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Bigot, P. Leblond, C. Foucher, V. Hue, M. D'Herbomez, and M. Foulard, “Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in children,” Archives de Pediatrie, vol. 12, no. 7, pp. 1075–1080, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. D. Tuerlinckx, T. Vander Borght, and T. Vander Borght, “Is procalcitonin a good marker of renal lesion in febrile urinary tract infection?” European Journal of Pediatrics, vol. 164, no. 10, pp. 651–652, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. Gervaix, A. Galetto-Lacour, T. Gueron, L. Vadas, S. Zamora, S. Suter, and E. Girardin, “Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection,” Pediatric Infectious Disease Journal, vol. 20, no. 5, pp. 507–511, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Benador, C. A. Siegrist, and C. A. Siegrist, “Procalcitonin is a marker of severity of renal lesions in pyelonephritis,” Pediatrics, vol. 102, no. 6, pp. 1422–1425, 1998. View at Google Scholar · View at Scopus
  23. H. Belhadj-Tahar, Y. Coulais, M. Tafani, and F. Bouissou, “Procalcitonin implication in renal cell apoptosis induced by acute pyelonephritis in children,” Infection and Drug Resistance, vol. 1, pp. 17–20, 2008. View at Google Scholar
  24. V. Smolkin, A. Koren, R. Raz, R. Colodner, W. Sakran, and R. Halevy, “Procalcitonin as a marker of acute pyelonephritis in infants and children,” Pediatric Nephrology, vol. 17, no. 6, pp. 409–412, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Nikfar, G. Khotaee, N. Ataee, and S. Shams, “Usefulness of procalcitonin rapid test for the diagnosis of acute pyelonephritis in children in the emergency department,” Pediatrics International, vol. 52, no. 2, pp. 196–198, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. G. Güven, H. Z. Kazdal, M. Koyun, F. Aydin, F. Güngör, S. Akman, and Y. E. Baysal, “Accurate diagnosis of acute pyelonephritis: how helpful is procalcitonin?” Nuclear Medicine Communications, vol. 27, no. 9, pp. 715–721, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. K. Karavanaki, F. A. Haliotis, and F. A. Haliotis, “DMSA scintigraphy in febrile urinary tract infections could be omitted in children with low procalcitonin levels,” Infectious Diseases in Clinical Practice, vol. 15, no. 6, pp. 377–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Mantadakis, E. Plessa, E. K. Vouloumanou, D. E. Karageorgopoulos, A. Chatzimichael, and M. E. Falagas, “Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies,” The Journal of Pediatrics, vol. 155, no. 6, pp. 875–881.e1, 2009. View at Google Scholar · View at Scopus
  29. S. Leroy, A. Fernandez-Lopez, R. Nifkar et al., Predictive ability of Procalcitonin for acute pyelonephrtitis and late renal scars in children with urinary tract infection in children: systematic review and meta-analysis on individual patient data, International Pediatrics Nephrology Association, New York, NY, USA, 2010, Pediatric Nephrology.
  30. G. Williams, J. T. Fletcher, S. I. Alexander, and J. C. Craig, “Vesicoureteral reflux,” Journal of the American Society of Nephrology, vol. 19, no. 5, pp. 847–862, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. A. Kotoula, S. Gardikis, and S. Gardikis, “Comparative efficacies of procalcitonin and conventional inflammatory markers for prediction of renal parenchymal inflammation in pediatric first urinary tract infection,” Urology, vol. 73, no. 4, pp. 782–786, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. M. Zaffanello, M. Brugnara, M. Franchini, and V. Fanos, “Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 10, pp. 1358–1363, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Hoberman, M. Charron, R. W. Hickey, M. Baskin, D. H. Kearney, and E. R. Wald, “Imaging studies after a first febrile urinary tract infection in young children,” New England Journal of Medicine, vol. 348, no. 3, pp. 195–202, 2003. View at Publisher · View at Google Scholar · View at PubMed
  34. S. Leroy, C. Adamsbaum, and C. Adamsbaum, “Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection,” Pediatrics, vol. 115, no. 6, pp. e706–e709, 2005. View at Publisher · View at Google Scholar · View at PubMed
  35. I. Chevalier and M. Gauthier, “Procalcitonin and vesicoureteral reflux in children with urinary tract infection,” Pediatrics, vol. 116, no. 5, pp. 1261–1262, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. S. Leroy, C. Romanello, and C. Romanello, “Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study,” Journal of Pediatrics, vol. 150, no. 1, pp. 89–95, 2007. View at Publisher · View at Google Scholar · View at PubMed
  37. S. Leroy, C. Romanello, A. Galetto-Lacour et al., Is procalcitonin a predictor for high-grade VUR in children even when considering DMSA-proven acute pyelonephritis? A meta-analysis of individual patient data, European Society of Pediatric Nephrology, Lyon, France, 2008.
  38. S. Leroy, C. Romanello, V. Smolkin et al., Prediction of high-grade vesicoureteral reflux after a first urinary tract infection in children: construction and internal validation of a clinical decision rule, International Pediatric Nephrology Association, New York, NY, US, 2010.
  39. P. Whiting, M. Westwood, and M. Westwood, “Clinical effectiveness and cost-effectiveness of tests for the diagnosis and investigtion of urinary tract infection in children: a systematic review and economic model,” Health Technology Assessment, vol. 10, no. 36, pp. 1–154, 2006. View at Google Scholar
  40. S. Leroy, S. Vantalon, A. Larakeb, H. Ducou-Le-Pointe, and A. Bensman, “Vesicoureteral reflux in children with urinary tract infection: comparison of diagnostic accuracy of renal US criteria,” Radiology, vol. 255, no. 3, pp. 890–898, 2010. View at Publisher · View at Google Scholar · View at PubMed
  41. A. Laupacis, N. Sekar, and I. G. Stiell, “Clinical prediction rules: a review and suggested modifications of methodological standards,” Journal of the American Medical Association, vol. 277, no. 6, pp. 488–494, 1997. View at Google Scholar
  42. T. G. McGinn, G. H. Guyatt, P. C. Wyer, C. D. Naylor, I. G. Stiell, and W. S. Richardson, “Users' guides to the medical literature XXII: how to use articles about clinical decision rules,” Journal of the American Medical Association, vol. 284, no. 1, pp. 79–84, 2000. View at Google Scholar